McKesson Corporation (MCK)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $127.33B
Last updated: Nov 17, 2026 at 11:06 AM ET
McKesson Corporation (MCK) Stock Forecast
Analysts expect McKesson (MCK) to earn $46.13 per share in the fiscal year ending Mar 31, 2027, on revenue of $435.46B. Of 16 analysts, 13 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 7 estimates for the fiscal year ending Mar 31, 2027 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 81% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 18.8% |
| Buy | 10 | 62.5% |
| Hold | 3 | 18.8% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 16
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 13.3% and revenue estimates rise 6.9%.
- Fiscal year ending Mar 31, 2027
- $46.13
- EPS consensus, revenue $435.46B
- Fiscal year ending Mar 31, 2028
- $52.26
- EPS consensus, revenue $465.36B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $46.13 | $45.93 to $46.40 | 13 | $435.46B | $432.64B to $439.18B | 14 |
| Mar 31, 2028 | $52.26 | $50.60 to $54.01 | 16 | $465.36B | $454.99B to $481.40B | 14 |
Quarterly Estimates
The EPS consensus rises from $10.95 for the quarter ending Dec 31, 2026 to $13.71 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $10.95 | $10.49 to $11.71 | 10 | $114.02B | $112.81B to $115.43B | 10 |
| Mar 31, 2027 | $13.71 | $12.43 to $15.01 | 17 | $105.60B | $100.94B to $113.59B | 15 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 10 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 7 | 0 |
| Fiscal year ending Mar 31, 2028 | 3 | 1 |
| Quarter ending Dec 31, 2026 | 0 | 4 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has risen 3.5% from $44.58.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $46.13 | $44.62 | $44.64 | $44.61 | $44.58 | +3.5% |
| Fiscal year ending Mar 31, 2028 | $52.26 | $50.63 | $50.70 | $50.57 | $50.53 | +3.4% |
| Quarter ending Dec 31, 2026 | $10.95 | $10.90 | $10.96 | $10.97 | $10.96 | -0.1% |
Frequently Asked Questions About MCK
What is the MCK stock forecast?
Consensus analyst estimates put McKesson's EPS at $46.13 for the fiscal year ending Mar 31, 2027, on revenue of $435.46B. The consensus rating from 16 analysts is Buy.
How do analysts rate MCK stock?
Of 16 analysts covering McKesson, 3 rate it Strong Buy, 10 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MCK next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $46.13, with estimates from $45.93 to $46.40 from 13 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $52.26, with estimates from $50.60 to $54.01 from 16 analysts.
What revenue do analysts expect from McKesson next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $435.46B, with estimates from $432.64B to $439.18B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $465.36B, with estimates from $454.99B to $481.40B.
How many analysts cover MCK?
16 analysts rate McKesson stock, and 13 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
MCK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts